z-logo
Premium
Assessment of the U.S. Environmental Protection Agency methods for identification of hazards to developing organisms, Part II: The developmental toxicity testing guideline
Author(s) -
Claudio Luz,
Bearer Cynthia F.,
Wallinga David
Publication year - 1999
Publication title -
american journal of industrial medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.7
H-Index - 104
eISSN - 1097-0274
pISSN - 0271-3586
DOI - 10.1002/(sici)1097-0274(199906)35:6<554::aid-ajim2>3.0.co;2-x
Subject(s) - agency (philosophy) , medicine , risk analysis (engineering) , guideline , environmental health , risk assessment , developmental toxicity , protocol (science) , identification (biology) , environmental planning , business , computer security , computer science , environmental science , pathology , alternative medicine , pregnancy , philosophy , gestation , botany , epistemology , biology , genetics
Background The effects of toxins on developing animals depend not only on the nature of the chemical but also on the timing of exposure and assessment of outcomes. This complicates the task of regulatory agencies such as the U.S. Environmental Protection Agency (EPA), which must comply with the 1996 Food Quality Protection Act to ensure that their standards and policies protect infants and children from environmental toxins. For this task, the Agency relies heavily on scientific data obtained by manufacturers of industrial chemicals and pesticides following protocols collected under EPA's Health Effects Test Guidelines. Methods and Results This article reviews the protocols included in the EPA guidelines to assess developmental toxicity, which are required for food‐use pesticides under the core testing battery. We reviewed these protocols on the basis of their adequacy for identifying hazards to infants and children. Our analysis found limitations in the protocols that hinder their potential for identifying developmental hazards. Conclusions Methods that the EPA currently depends upon to identify developmental toxicity of chemicals have limitations that impede obtaining complete and reliable data on which to base regulatory decisions that protect children. Other methodological approaches need to be explored as alternatives or supplements to the current protocols. Until more accurate testing protocols become available, it may well be necessary under existing laws to employ safety factors that are more protective of the health of children at all stages of development. Am. J. Ind. Med. 35:554–563, 1999. © 1999 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here